Navigation Links
From Microscope to Stethoscope: the MUHC's distinguished public lecture series begins a second seaso
Date:9/28/2007

Montreal, September 28th, 2007 - From Microscope to Stethoscope, the distinguished public lecture series organized by the Research Institute of the McGill University Health Centre (MUHC), is embarking on a second season. "Again this year, three of our most brilliant researchers invite you on a journey into a possible future, when current research has already turned into innovative treatments for patients, declared Dr. Arthur T. Porter, Director General of the MUHC. These lectures will give you a direct look at the intellectual vitality that fills our research laboratories and the enormous impact of this work on our daily lives.

Dr. Vassilios Papadopoulos, Director of the Research Institute of the MUHC, will open the lecture series on Wednesday, October 3, 2007 by sharing the hope that his current research may bring to patients suffering from Alzheimers disease. His latest laboratory findings could lead to remarkable therapeutic advances and relieve the difficulties doctors currently have in terms of diagnosis and treatment.

Dr. Lawrence Rosenberg, a world expert in diabetes, will present the second lecture on Monday, November 7, 2007, followed by Dr. Ronald Olivenstein, MUHC Asthma Clinic Director, on Wednesday, December 3, 2007.

The lectures will take place at the Montreal General Hospital in Livingston Hall (Rom L6-500) starting at 7:30 p.m. Admission is free and anyone interested is welcome.

The speakers will take questions from audience members during a discussion period following each lecture.


'/>"/>

Contact: Isabelle Kling
isabelle.kling@muhc.mcgill.ca
514-934-1934
McGill University Health Centre
Source:Eurekalert

Page: 1

Related medicine news :

1. Distinguished Scientist Award Conferred on Manchester Dentist
2. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
3. Controversial deal on public access of the human genome map
4. Defibrillators In Public Places Will Help Cardiac Patients
5. WHO To Support Public Health Threats
6. Public Defibrillators Found To Improve Survival Rate
7. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
8. WHO Steps Up To Create A Public Awareness About The Consequences Of Exposure To Radon
9. Disaster Planning Guide From Harvard Health Publications
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. Smoking Ban Believed To Enjoy Widespread Public Acceptance In Scotland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is a ... smoothing and tightening the skin of the face to create more youthful features. ... with very little downtime, Silhouette Instalift is a novel, minimally invasive facial procedure ...
(Date:12/7/2016)... , ... December 07, 2016 , ... It is vital ... is with useful, properly analyzed data. The team at Beckman Coulter has designed Kaluza, ... 'need for speed' and the need to operate in a GLP (Good Laboratory Practice) ...
(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles ... minutes later, the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised ... teen the hospital’s 30th heart transplant recipient. , “He was playing at home, when ...
(Date:12/7/2016)... ... ... One of two inventors from Glen Burnie, Md., has a granddaughter who ... is why the co-inventor and I have designed a new and better way to ... of the patent-pending AV-AIR, a device that serves as an alternative to conventional methods ...
(Date:12/7/2016)... ... 2016 , ... The Honolulu cosmetic and medical dermatology practice ... October 17, 2016, features comprehensive information regarding a wide range of dermatologic conditions, ... can discover the latest clinical dermatology treatments for medical skin concerns as well ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... PARK , Israel , December 7, ... announced today the signing of a memorandum of understanding with Korean ... synergy between the companies will assist in expediting Kadimastem,s entry into ... in innovative treatment for severe diseases in general and ALS and ... , , ...
(Date:12/7/2016)... , Dec. 7, 2016  Organovo Holdings, ... three-dimensional biology company focused on delivering scientific and ... announced that Chairman and Chief Executive Officer ... VirtualInvestorConferences.com on Wednesday, December 14, 2016 at 1:00 ... who are not yet familiar with the Company, ...
(Date:12/7/2016)... 7, 2016 The global  ... value of USD 3.9 billion by 2024, based ... Inc. The growth of the market is attributed ... technological advancements by the market players. Demand for ... increasing donation, rising awareness about transfusion-transmitted diseases, and ...
Breaking Medicine Technology: